EA201290959A1 - Соединения аденозина и их применения - Google Patents
Соединения аденозина и их примененияInfo
- Publication number
- EA201290959A1 EA201290959A1 EA201290959A EA201290959A EA201290959A1 EA 201290959 A1 EA201290959 A1 EA 201290959A1 EA 201290959 A EA201290959 A EA 201290959A EA 201290959 A EA201290959 A EA 201290959A EA 201290959 A1 EA201290959 A1 EA 201290959A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- adenosine
- applications
- directed
- benzyloxycyclopentyladenosine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение направлено на соединения бензилоксициклопентиладенозина (ВСРА) и на их применение в качестве избирательных агонистов аденозинового рецептора A. В частности, соединения данного изобретения направлены на применение для снижения и/или контроля повышенного или аномально меняющегося IOP у субъектов при лечении глаукомы или глазной гипертензии (ОНТ).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31797210P | 2010-03-26 | 2010-03-26 | |
PCT/US2011/029929 WO2011119919A1 (en) | 2010-03-26 | 2011-03-25 | Adenosine compounds and their use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201290959A1 true EA201290959A1 (ru) | 2013-04-30 |
Family
ID=44673647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201290959A EA201290959A1 (ru) | 2010-03-26 | 2011-03-25 | Соединения аденозина и их применения |
Country Status (15)
Country | Link |
---|---|
US (1) | US8501708B2 (ru) |
EP (1) | EP2552932A4 (ru) |
JP (1) | JP2013523738A (ru) |
KR (1) | KR20130029049A (ru) |
CN (1) | CN102822188A (ru) |
AU (1) | AU2011230618A1 (ru) |
BR (1) | BR112012023747A2 (ru) |
CA (1) | CA2792265A1 (ru) |
CL (1) | CL2012002612A1 (ru) |
CO (1) | CO6620038A2 (ru) |
EA (1) | EA201290959A1 (ru) |
MX (1) | MX2012010723A (ru) |
SG (1) | SG184223A1 (ru) |
WO (1) | WO2011119919A1 (ru) |
ZA (1) | ZA201207089B (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ME02608B (me) | 2010-01-11 | 2017-06-20 | Inotek Pharmaceuticals Corp | Kombinacija, komplet i postupak snižavanja intraokularnog pritiska |
BR112012023749A2 (pt) | 2010-03-26 | 2016-08-23 | Inotek Pharmaceuticals Corp | método para reduzir a pressão intraocular em humanos utilizando n6-ciclopentiladenosina (cpa), derivados de cpa ou pró-fármacos desses |
SG11201403979TA (en) | 2012-01-26 | 2014-08-28 | Inotek Pharmaceuticals Corp | Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) } methyl nitrate and processes of preparation thereof |
EP2968389A4 (en) | 2013-03-15 | 2016-08-24 | Inotek Pharmaceuticals Corp | OPHTHALMIC FORMULATIONS |
AU2015358576A1 (en) * | 2014-12-03 | 2017-06-22 | Inotek Pharmaceuticals Corporation | Methods of preventing, reducing or treating macular degeneration |
EP3226976A1 (en) | 2014-12-04 | 2017-10-11 | Mary Kay, Inc. | Topical skin care composition comprising trifluoroacetyl tripeptide-2 |
CN109512710A (zh) | 2017-09-18 | 2019-03-26 | 玫琳凯有限公司 | 化妆品组合物及方法 |
GB2582361A (en) | 2019-03-21 | 2020-09-23 | Univ Warwick | Adenosine receptor agonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK62692D0 (ru) | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
US7713946B2 (en) | 2002-07-11 | 2010-05-11 | Cv Therapeutics, Inc. | Partial and full agonists A1 adenosine receptors |
RS51261B (sr) | 2004-05-26 | 2010-12-31 | Inotek Pharmaceuticals Corporation | Derivati purina kao agonisti receptora adenozina a1 i postupci za njihovu upotrebu |
US7271157B2 (en) | 2004-07-12 | 2007-09-18 | Cv Therapeutics, Inc. | A1 adenosine receptor agonists |
JP2008266143A (ja) * | 2007-04-16 | 2008-11-06 | Santen Pharmaceut Co Ltd | アデノシン誘導体を有効成分として含有する緑内障治療剤 |
EP2259790A1 (en) * | 2008-02-07 | 2010-12-15 | Gilead Palo Alto, Inc. | Abca-1 elevating compounds and the use thereof |
-
2011
- 2011-03-25 KR KR1020127023969A patent/KR20130029049A/ko not_active Application Discontinuation
- 2011-03-25 CA CA2792265A patent/CA2792265A1/en not_active Abandoned
- 2011-03-25 US US13/071,993 patent/US8501708B2/en not_active Expired - Fee Related
- 2011-03-25 SG SG2012070603A patent/SG184223A1/en unknown
- 2011-03-25 WO PCT/US2011/029929 patent/WO2011119919A1/en active Application Filing
- 2011-03-25 MX MX2012010723A patent/MX2012010723A/es not_active Application Discontinuation
- 2011-03-25 EP EP11760282.1A patent/EP2552932A4/en not_active Withdrawn
- 2011-03-25 BR BR112012023747A patent/BR112012023747A2/pt not_active IP Right Cessation
- 2011-03-25 EA EA201290959A patent/EA201290959A1/ru unknown
- 2011-03-25 CN CN2011800162848A patent/CN102822188A/zh active Pending
- 2011-03-25 AU AU2011230618A patent/AU2011230618A1/en not_active Abandoned
- 2011-03-25 JP JP2013502668A patent/JP2013523738A/ja not_active Withdrawn
-
2012
- 2012-09-20 ZA ZA2012/07089A patent/ZA201207089B/en unknown
- 2012-09-21 CL CL2012002612A patent/CL2012002612A1/es unknown
- 2012-10-17 CO CO12183287A patent/CO6620038A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO6620038A2 (es) | 2013-02-15 |
ZA201207089B (en) | 2014-03-26 |
MX2012010723A (es) | 2012-11-12 |
US8501708B2 (en) | 2013-08-06 |
KR20130029049A (ko) | 2013-03-21 |
WO2011119919A1 (en) | 2011-09-29 |
EP2552932A4 (en) | 2013-08-21 |
CA2792265A1 (en) | 2011-09-29 |
CL2012002612A1 (es) | 2012-12-21 |
AU2011230618A1 (en) | 2012-10-11 |
EP2552932A1 (en) | 2013-02-06 |
JP2013523738A (ja) | 2013-06-17 |
SG184223A1 (en) | 2012-10-30 |
BR112012023747A2 (pt) | 2016-08-23 |
CN102822188A (zh) | 2012-12-12 |
US20110245194A1 (en) | 2011-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201290959A1 (ru) | Соединения аденозина и их применения | |
MX2013001204A (es) | Compuesto para el tratamiento/prevencion de enfermedades inflamatorias oculares. | |
EA201071169A1 (ru) | ГИДРОКСИМЕТИЛПИРРОЛИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ β3 | |
CY1117458T1 (el) | Αγωνιστες αδενοσινης α1 για τη θεραπευτικη αντιμετωπιση του γλαυκωματος και της οφθαλμικης υπερτασης | |
EA201071264A1 (ru) | Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера | |
EA201101138A1 (ru) | Соединение с конденсированным кольцом и его применение | |
EA201490543A1 (ru) | Производные бициклических гетероциклов для лечения пульмонарной артериальной гипертонии | |
CY1121787T1 (el) | Sirna και χρηση αυτων σε μεθοδους και συνθεσεις για τη θεραπεια ή/και προληψη οφθαλμικων καταστασεων | |
EA201492163A1 (ru) | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К TrkA, СОДЕРЖАЩИЕ АМИНОКИСЛОТНЫЕ ЗАМЕНЫ | |
EA201490790A1 (ru) | Пептидные конъюгаты агониста рецептора гастрина и глюкагон подобного пептида 1 | |
EA201590827A1 (ru) | Новые производные пиразина в качестве агонистов каннабиноидного рецептора 2 | |
EA201301332A1 (ru) | ОФТАЛЬМОЛОГИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ АНАЛОГ PGF2α | |
EA201491002A1 (ru) | Производные [1,2,3]триазоло[4,5-d]пиримидина в качестве агонистов каннабиноидного рецептора 2 | |
MA37618A1 (fr) | Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx | |
NZ704178A (en) | Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions | |
EA201590823A1 (ru) | 6-((s)-1-{1-[5-(2-гидроксиэтокси)пиридин-2-ил]-1h-пиразол-3-ил}этил)-3h-1,3-бензотиазол-2-он в качестве антагониста tarp-гамма 8-зависимого ampa-рецептора | |
CL2007003836A1 (es) | Uso de compuestos derivados de isosorbide en la prevencion y/o tratamiento de enfermedades oftalmologicas mediadas por hipertension ocular, tales como glaucoma. | |
MA32224B1 (fr) | Derives de (pyrazolyl-carbonyl) imidazolidinone pour le traitement de maladies retrovirales | |
UY34843A (es) | Tratamiento de enfermedades inflamatorias oculares usando laquinimod | |
UY34543A (es) | Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica. | |
ITMI20070890A1 (it) | Composizioni oftalmiche per il trattamento della ipertensione oculare e del glaucoma | |
EA201290958A1 (ru) | Способ снижения внутриглазного давления у людей с применением n6-циклопентиладенозина (cpa), производных cpa или их пролекарств | |
DOP2010000156A (es) | Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca | |
UY30135A1 (es) | Quinolonas sustituidas iii | |
UY33562A (es) | Agonistas de receptores de bradicinina y su utilización para el tratamiento de la hipertensión ocular y el glaucoma |